Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ISRCTN56505721) titled 'Myoinositol in adolescent polycystic ovary syndrome' on May 19.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Blinded (masking used)
Control: Placebo
Assignment: Parallel
Purpose: Device feasibility, Health services research, Supportive care
Primary Sponsor: University of Birmingham
Condition:
Polycystic ovary syndrome
Nutritional, Metabolic, Endocrine
Intervention:
Myoinositol 2 g BD (twice a day) or placebo for 6 months
Participants are randomised by the REDCap database using a 1:1 allocation ratio (myoinositol vs placebo). A minimisation algorithm is used withi...